Chile · Delayed Price · Currency is CLP AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of CLP 356.82 trillion. The enterprise value is 411.63 trillion.
| Market Cap | 356.82T |
| Enterprise Value | 411.63T |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 16, 2026 |
Share Statistics
| Current Share Class | 1.77B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 74.86% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 93.73 and the forward PE ratio is 15.96.
| PE Ratio | 93.73 |
| Forward PE | 15.96 |
| PS Ratio | 6.48 |
| PB Ratio | -152.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 108.13 |
| EV / Sales | 7.76 |
| EV / EBITDA | 16.14 |
| EV / EBIT | 22.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.34 |
| Debt / FCF | n/a |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.00B |
| Profits Per Employee | 69.21M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 2.13 trillion in taxes.
| Income Tax | 2.13T |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
The stock price has decreased by -5.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.00% |
| 50-Day Moving Average | 171,590.00 |
| 200-Day Moving Average | 171,590.00 |
| Relative Strength Index (RSI) | 29.67 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, AbbVie had revenue of CLP 55.09 trillion and earned 3.81 trillion in profits. Earnings per share was 2,125.82.
| Revenue | 55.09T |
| Gross Profit | 39.47T |
| Operating Income | 19.11T |
| Pretax Income | 5.94T |
| Net Income | 3.81T |
| EBITDA | 26.50T |
| EBIT | 19.11T |
| Earnings Per Share (EPS) | 2,125.82 |
Balance Sheet
The company has 5.11 trillion in cash and 62.02 trillion in debt, with a net cash position of -56,908.85 billion.
| Cash & Cash Equivalents | 5.11T |
| Total Debt | 62.02T |
| Net Cash | -56,908.85B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2,341.10B |
| Book Value Per Share | -1,346.55 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.
| Gross Margin | 71.64% |
| Operating Margin | 34.69% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 48.10% |
| EBIT Margin | 34.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 6,282.40, which amounts to a dividend yield of 3.66%.
| Dividend Per Share | 6,282.40 |
| Dividend Yield | 3.66% |
| Dividend Growth (YoY) | 103.49% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 295.53% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 3.44% |
| Earnings Yield | 1.07% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |